Back to Trades
Robinson Chandler
Chief Executive OfficerDirectorCIK 0001727334
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 5
- Companies
- 1
- Active
- 2025–2026
Robinson Chandler, Chief Executive Officer, Director, accounts for 10 disclosed filings worth $7.0M, all concentrated in Monopar Therapeutics (MNPR), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $3.2M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Oct 20 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Tax withheld | $55.3K |
| Oct 2 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Exercise | $346.1K |
| Sep 28 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Sell | $2.6M |
| Jul 2 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Exercise | $378.1K |
| Apr 2 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Exercise | $108.0K |
| Jan 30 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Other | $0 |
| Jan 5 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Exercise | $167.0K |
| Dec 8 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Award | $1.3M |
| Oct 2 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Exercise | $216.1K |
| Jul 16 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Sell | $672.0K |
10 filings